Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer

NCT03081819 is registered in ClinicalTrials.gov with Kyunghee University Medical Center as lead sponsor.

NCT NCT03081819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03081819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer
Lead sponsor
Kyunghee University Medical Center
Phase
Phase 1
Overall status
Completed
Start date
March 29, 2017
Completion date
July 25, 2019
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor, adult